Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00087256 · ClinicalTrials.gov registry record · Phase 3
Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer
A Phase 3 study, sponsored by NSABP Foundation.
- Terminated
- Registry status
- Phase 3
- Development phase
- 18
- Enrollment target
NCT00087256 is a Phase 3 study that was terminated before completion, run by NSABP Foundation. The registered enrollment target is 18 participants.
The verdict
NCT00087256, a Phase 3 study, was terminated before completion, sponsored by NSABP Foundation.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 18 participants
- Enrollment target
Study Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. It is not yet known whether celecoxib is effective in preventing polyps in patients with colon cancer. PURPOSE: Randomized phase III trial to study the effectiveness of celecoxib in preventing the development of polyps in patients who have undergone surgery for stage I colon cancer.
Interventions
- DRUG Celecoxib
- OTHER placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2004-07 |
| Est. Completion | 2006-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00087256
The ClinicalTrials.gov registry entry for NCT00087256 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NSABP Foundation, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Celecoxib is the first listed.
NCT00087256 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00087256 about?
NCT00087256 is a clinical study titled "Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer". RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. It is not yet known whether celecoxib is effective in preventing polyps in patients with colon cancer. PURPOSE: Randomized phase III trial to study the effectiveness of celecoxib in preventin...
What is the current status of trial NCT00087256?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 18 participants. The study started on 2004-07. Estimated completion is 2006-04.
What interventions are being tested in trial NCT00087256?
The interventions under investigation include: Celecoxib (DRUG), placebo (OTHER).
Who is sponsoring clinical trial NCT00087256?
This trial is sponsored by NSABP Foundation, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.